JASON EHRLICH - 12 May 2021 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)

Role
Chief Medical Officer and Chief Development Officer
Signature
/s/ Carlton Fleming, Attorney-in-Fact for Jason Ehrlich
Issuer symbol
KOD
Transactions as of
12 May 2021
Net transactions value
+$74,240
Form type
4
Filing time
14 May 2021, 17:22:57 UTC
Next filing
24 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KOD Common Stock Options Exercise $55,350 +5,379 +8.6% $10.29 68,222 12 May 2021 Direct
transaction KOD Common Stock Options Exercise $18,890 +1,889 +2.8% $10.00 70,111 12 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KOD Stock Option (Right to Buy) Options Exercise $0 -5,379 -2% $0.000000 258,546 12 May 2021 Common Stock 5,379 $10.29 Direct F1
transaction KOD Stock Option (Right to Buy) Options Exercise $0 -1,889 -3.3% $0.000000 54,793 12 May 2021 Common Stock 1,889 $10.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.
F2 One-sixtieth of the shares subject to the option vested on November 3, 2018, and 1/60th of the shares subject to the option vest on the same day of each month thereafter.

Remarks:

Chief Medical Officer and Chief Development Officer